glutathione heart failure system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis GLUTATHIONE and Cardiovascular (Heart) disease

But as any functional practitioner knows, its rarely that simple

This led to the discovery that the levels of S -nitroso-l-glutathione (GSNO) were significantly reduced in an experimental murine Staphylococcus aureus (SA) endophthalmitis model

HBOT for inflammation and recovery

Do not use on wounds or other affected areas

Thus, the use of this approach allowed to identify an original target, the protein kinase DYRK1B, suggesting that an inhibitor of this protein could present a possible senolytic activity 40

Most of the positive data on BPC-157 comes from animal studies and numerous anecdotal cases from athletes, as opposed to human trials